Trial Profile
Phase I/II trial of oral AD 6626 in patients with Fanconi's anaemia
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 11 Nov 2014
Price :
$35
*
At a glance
- Drugs AD 6626 (Primary)
- Indications Fanconi's anaemia
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Sponsors ALDEA Pharmaceuticals
- 11 Nov 2014 New trial record